Onconova Therapeutics
ONTX
#9639
Rank
ยฃ16.58 M
Marketcap
ยฃ0.79
Share price
-0.47%
Change (1 day)
-11.00%
Change (1 year)

Revenue for Onconova Therapeutics (ONTX)

Revenue in 2024 (TTM): ยฃ0.18 Million

According to Onconova Therapeutics's latest financial reports the company's current revenue (TTM ) is ยฃ0.17 Million. In 2023 the company made a revenue of ยฃ0.17 Million a decrease over the revenue in the year 2022 that were of ยฃ0.18 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Onconova Therapeutics from 2012 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) ยฃ0.18 M1.6%
2023 ยฃ0.17 M-5.04%
2022 ยฃ0.18 M11.58%
2021 ยฃ0.16 M-1.21%
2020 ยฃ0.16 M-89.82%
2019 ยฃ1.66 M72.08%
2018 ยฃ0.96 M66.13%
2017 ยฃ0.58 M-87.04%
2016 ยฃ4.49 M-41.86%
2015 ยฃ7.73 M1404.46%
2014 ยฃ0.51 M-82.17%
2013 ยฃ2.88 M-89.92%
2012 ยฃ28.57 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ยฃ20.41 M 11,284.51%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ0.87 B 487,166.37%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ11.89 B 6,635,740.71%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ60.12 M 33,426.11%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ0.5 M 179.58%๐Ÿ‡บ๐Ÿ‡ธ USA